ENACT

Serial Number 90618229
606

Registration Progress

Application Filed
Apr 1, 2021
Under Examination
Feb 8, 2022
Approved for Publication
Dec 14, 2021
Published for Opposition
Dec 14, 2021
Registered

Trademark Image

ENACT

Basic Information

Serial Number
90618229
Filing Date
April 1, 2021
Published for Opposition
December 14, 2021
Abandonment Date
March 13, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 13, 2023
Classes
044

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl Foytlin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Mar 13, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 13, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 4, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 2, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 2, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 2, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 8, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 14, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 9, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 5, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical services; medical services, namely, providing advisory services, information and consultancy regarding the support of patients with cardiovascular diseases, including nervous thromboembolism patients through transition in sites of care
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
044